Home

Independent European equity research

The research desk,without theresearch budget.

Concise, independent views on hundreds of European listed companies. Written by hedge fund managers and former sell-side analysts for investors who want the substance of broker research at a fraction of the cost.

569Companies covered
104Editions
1,259Company takes
40,000+Subscribers
Our read, last 12 editions45% positive
6 Oct 2026: 12 companies, 6 positive, 4 neutral, 2 negative8 Oct 2026: 12 companies, 4 positive, 4 neutral, 4 negative13 Oct 2026: 11 companies, 4 positive, 6 neutral, 1 negative15 Oct 2026: 10 companies, 4 positive, 4 neutral, 2 negative20 Oct 2026: 13 companies, 8 positive, 2 neutral, 3 negative22 Oct 2026: 14 companies, 8 positive, 4 neutral, 2 negative27 Oct 2026: 14 companies, 9 positive, 5 neutral, 0 negative29 Oct 2026: 16 companies, 8 positive, 4 neutral, 4 negative3 Nov 2026: 16 companies, 6 positive, 5 neutral, 5 negative5 Nov 2026: 20 companies, 10 positive, 8 neutral, 2 negative10 Nov 2026: 29 companies, 8 positive, 13 neutral, 8 negative12 Nov 2026: 26 companies, 11 positive, 11 neutral, 4 negative
6 Oct 202612 Nov 2026
PositiveNeutralNegative

Why Lux Opes

What the big houses sell, minus the overhead.

Large research houses bundle basic maintenance research and 50+ page reports full of fluff into one expensive package. We keep the part professionals actually use: what changed at a company, and why it matters.

01 — Coverage

Pan-European, large to small.

569 companies across 21 countries so far, from index heavyweights to the small and mid caps that brokers have stopped covering.

02 — Signal

The point, not the padding.

No 50-page reports. Each company gets what moved and what it means for the investment case, in a few lines you can read between meetings.

03 — Independence

No ratings. No banking ties.

We don’t issue buy or sell calls and have no corporate finance business to protect. You bring the judgement; we bring the information.

The comparison

Traditional research vs Lux Opes.

Since MiFID II, research has had a price tag, and most of it is set for institutional budgets. Here is where we differ.

Broker & bank researchLux Opes
CostInstitutional research budgetsA fraction of that
FormatLong PDFs, model updates, daily flowMaterial, concise and to the point
CoverageSplit by sector desk; small caps thinning outOne feed across 569 European companies
RatingsBuy, hold, sell and price targetsNo calls, but we share our view
ConflictsCorporate access and banking relationshipsNo corporate finance business
HistoryAccess tied to the client relationshipFull archive and coverage tracker included

The coverage

Every company, every edition, one place.

Search all 569 companies we’ve written about, see how our view has moved over time, and jump straight to each edition.

Open the coverage tracker
167121673836342917
Companies covered1–45–1415–3940–99100+
Temperament matters as much as fundamentals. On the fundamentals, we can help.Lux Opes Research
  • 01
    No long reportsConcise by design, so you can cover more ground.
  • 02
    No multi-bagger promisesJust material information, clearly framed.
  • 03
    No buy or sell callsThe decision stays yours, but we always share our view.
  • 04
    The full archiveEvery edition and every company since January 2025.

Join 40,000+ investors

Cover more of Europe, for less.

The European companies that matter, framed by people who have worked on both the buy side and the sell side.

Lux Opes Research provides information and commentary only. Nothing here is investment advice or a recommendation to buy or sell any security.